SCHEMBL29566361

SCHEMBL29566361

CC(C)c1ccccc1-c1cc(OCC2CC2)nc(NS(=O)(=O)c2cccc([N+](=O)[O-])c2)n1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ AR P10275 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ PGR P06401 1/20 0.39
▸ NFKBIA P25963 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ DDX3X O00571 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ EDNRA P25101 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ TYMS P04818 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29566848 0.86 POLB (0.37) ALDH1A1MAPTCYP19A1
SCHEMBL26806781 0.86 POLB (0.37) ALDH1A1MAPTCYP19A1
SCHEMBL29567669 0.85 LMNA (0.45) LMNAALDH1A1KDM4EMAPTAR
SCHEMBL26806595 0.82 LMNA (0.47) LMNAALDH1A1KDM4EMAPTMEN1
SCHEMBL29566410 0.81 LMNA (0.49) LMNAALDH1A1KDM4EMAPTMEN1
SCHEMBL26806638 0.81 LMNA (0.49) LMNAALDH1A1KDM4EMAPTMEN1
SCHEMBL29566406 0.81 LMNA (0.49) LMNAALDH1A1KDM4EMAPTMEN1
SCHEMBL26806641 0.81 LMNA (0.49) LMNAALDH1A1KDM4EMAPTMEN1
SCHEMBL26806784 0.75 POLB (0.41) LMNAALDH1A1KDM4EMAPTKMT2A
SCHEMBL24309602 0.74 PGR (0.56) LMNAALDH1A1KDM4EMAPTAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback